A detailed history of Chevy Chase Trust Holdings, Inc. transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Chevy Chase Trust Holdings, Inc. holds 330,393 shares of EW stock, worth $21.9 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
330,393
Previous 333,855 1.04%
Holding current value
$21.9 Million
Previous $30.8 Million 29.3%
% of portfolio
0.07%
Previous 0.1%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$59.7 - $93.78 $206,681 - $324,666
-3,462 Reduced 1.04%
330,393 $21.8 Million
Q2 2024

Jul 22, 2024

SELL
$84.3 - $94.31 $745,127 - $833,606
-8,839 Reduced 2.58%
333,855 $30.8 Million
Q1 2024

May 03, 2024

SELL
$72.54 - $95.56 $214,645 - $282,762
-2,959 Reduced 0.86%
342,694 $32.7 Million
Q4 2023

Jan 24, 2024

SELL
$61.71 - $77.76 $146,869 - $185,068
-2,380 Reduced 0.68%
345,653 $26.4 Million
Q3 2023

Oct 23, 2023

SELL
$69.28 - $93.38 $493,065 - $664,585
-7,117 Reduced 2.0%
348,033 $24.1 Million
Q2 2023

Jul 25, 2023

SELL
$81.41 - $94.33 $857,898 - $994,049
-10,538 Reduced 2.88%
355,150 $33.5 Million
Q1 2023

May 17, 2023

BUY
$74.26 - $84.51 $27.2 Million - $30.9 Million
365,688 New
365,688 $30.3 Million
Q4 2022

Feb 09, 2023

SELL
$68.3 - $87.44 $1.57 Million - $2.01 Million
-22,935 Reduced 5.95%
362,271 $27 Million
Q3 2022

Nov 04, 2022

BUY
$82.37 - $107.29 $167,622 - $218,335
2,035 Added 0.53%
385,206 $31.8 Million
Q2 2022

Aug 10, 2022

BUY
$86.5 - $128.27 $28,891 - $42,842
334 Added 0.09%
383,171 $36.4 Million
Q1 2022

Apr 27, 2022

BUY
$101.96 - $128.34 $98,187 - $123,591
963 Added 0.25%
382,837 $45.1 Million
Q4 2021

Jan 31, 2022

SELL
$106.37 - $130.68 $979,880 - $1.2 Million
-9,212 Reduced 2.36%
381,874 $49.5 Million
Q3 2021

Oct 20, 2021

SELL
$102.91 - $122.75 $1.38 Million - $1.64 Million
-13,398 Reduced 3.31%
391,086 $44.3 Million
Q2 2021

Jul 20, 2021

SELL
$83.84 - $104.76 $1.92 Million - $2.4 Million
-22,943 Reduced 5.37%
404,484 $41.9 Million
Q1 2021

Apr 22, 2021

SELL
$78.68 - $90.67 $2.77 Million - $3.19 Million
-35,174 Reduced 7.6%
427,427 $35.8 Million
Q4 2020

Feb 12, 2021

SELL
$71.69 - $91.23 $666,358 - $847,982
-9,295 Reduced 1.97%
462,601 $42.2 Million
Q3 2020

Nov 06, 2020

SELL
$67.19 - $87.44 $2.54 Million - $3.31 Million
-37,802 Reduced 7.42%
471,896 $37.7 Million
Q2 2020

Aug 14, 2020

BUY
$57.54 - $76.95 $18.9 Million - $25.3 Million
328,759 Added 181.7%
509,698 $35.2 Million
Q1 2020

May 13, 2020

BUY
$52.41 - $81.0 $155,919 - $240,975
2,975 Added 1.67%
180,939 $34.1 Million
Q4 2019

Feb 12, 2020

BUY
$71.7 - $82.09 $67,684 - $77,492
944 Added 0.53%
177,964 $13.8 Million
Q3 2019

Nov 20, 2019

SELL
$61.55 - $75.43 $23,204 - $28,437
-377 Reduced 0.21%
177,020 $13 Million
Q2 2019

Aug 14, 2019

BUY
$55.74 - $64.41 $30,378 - $35,103
545 Added 0.31%
177,397 $32.8 Million
Q1 2019

May 13, 2019

BUY
$47.89 - $64.05 $50,380 - $67,380
1,052 Added 0.6%
176,852 $31.2 Million
Q4 2018

Feb 14, 2019

SELL
$46.41 - $56.94 $64,231 - $78,804
-1,384 Reduced 0.78%
175,800 $26.9 Million
Q3 2018

Oct 23, 2018

SELL
$45.7 - $58.03 $256,514 - $325,722
-5,613 Reduced 3.07%
177,184 $30.8 Million
Q2 2018

Aug 02, 2018

SELL
$42.45 - $51.3 $4,924 - $5,950
-116 Reduced 0.06%
182,797 $26.6 Million
Q1 2018

Apr 10, 2018

SELL
$37.19 - $47.45 $248,615 - $317,203
-6,685 Reduced 3.53%
182,913 $25.5 Million
Q4 2017

Jan 22, 2018

SELL
$33.79 - $39.39 $6,453 - $7,523
-191 Reduced 0.1%
189,598 $21.4 Million
Q3 2017

Nov 14, 2017

BUY
$36.29 - $38.83 $6.89 Million - $7.37 Million
189,789
189,789 $20.7 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Chevy Chase Trust Holdings, Inc. Portfolio

Follow Chevy Chase Trust Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chevy Chase Trust Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Chevy Chase Trust Holdings, Inc. with notifications on news.